Curasight A/S reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was DKK 18.35 million compared to DKK 11.12 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.5 DKK | +5.00% | +5.63% | -40.85% |
Apr. 16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
Apr. 12 | Curasight A/S Announces Board Changes | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.85% | 30.15M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CURAS Stock
- News Curasight A/S
- Curasight A/S Reports Earnings Results for the Full Year Ended December 31, 2022